Zealand Pharma A/S (ZEAL)
NASDAQ: ZEAL
· Real-Time Price · USD
17.59
0.00 (0.00%)
At close: Sep 29, 2022, 10:00 PM
Revenue by Geography
| Period Ending | Dec 31, 2021 |
|---|---|
| Us Revenue | 239.6M |
| Us Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 10, 2022 | Sep 30, 2021 | Sep 6, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 85.16M | 148.31M | 156.31M | 182.13M | 149.5M | 204.51M | 138M | 120.44M | 25.08M | 16.67M | 16.02M | 20.74M | 14.46M | 13.39M | 43.62M | 14.75M | 6.23M | 16.48M | 7.94M | 13.17M | 9.89M | 21.64M | 2.06M | 20.8M | 8M | 16.61M | 8.91M | 11.6M | 7.49M |
| Selling, General, and Administrative Revenue Growth | -42.58% | -5.12% | -14.17% | +21.82% | -26.90% | +48.20% | +14.57% | +380.32% | +50.43% | +4.06% | -22.74% | +43.45% | +7.91% | -69.29% | +195.78% | +136.59% | -62.17% | +107.65% | -39.74% | +33.21% | -54.31% | +950.95% | -90.10% | +159.97% | -51.82% | +86.31% | -23.14% | +54.83% | n/a |
| Research and Development Revenue | 152.53M | 141.3M | 162.19M | 149.66M | 135.31M | 173.09M | 139.33M | 127.01M | 164.65M | 180.69M | 123.82M | 135.42M | 121.49M | 137.75M | 84.3M | 130.47M | 85.7M | 103.46M | 69.06M | 91.45M | 60.7M | 76.9M | 53.57M | 74.51M | 63.16M | 55.99M | 44.69M | 62.48M | 51.8M |
| Research and Development Revenue Growth | +7.95% | -12.88% | +8.37% | +10.61% | -21.83% | +24.23% | +9.71% | -22.86% | -8.88% | +45.93% | -8.57% | +11.47% | -11.80% | +63.41% | -35.39% | +52.25% | -17.17% | +49.82% | -24.48% | +50.67% | -21.08% | +43.55% | -28.10% | +17.97% | +12.81% | +25.29% | -28.47% | +20.63% | n/a |
| Sales and Marketing Revenue | 34.55M | 78.82M | 93.58M | 120.93M | 81.93M | 112.97M | 97.43M | 74.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -56.17% | -15.77% | -22.62% | +47.60% | -27.48% | +15.96% | +30.16% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |